These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36849405)

  • 1. An Unusual Presentation Of Steven-Johnson Syndrome After Bnt162b2 Covid-19 Vaccination.
    Patel R; Lu V
    J Ayub Med Coll Abbottabad; 2023; 35(1):180-181. PubMed ID: 36849405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic epidermal necrolysis after first dose of Pfizer-BioNTech (BNT162b2) vaccination with pharmacogenomic testing.
    Siripipattanamongkol N; Rattanasak S; Taiyaitieng C; Inthajak Y; Kuawatcharawong N; Sukasem C; Tempark T
    Pediatr Dermatol; 2022 Jul; 39(4):601-605. PubMed ID: 36000937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stevens-Johnson syndrome post second dose of Pfizer COVID-19 vaccine: a case report.
    Elboraey MO; Essa EESF
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Oct; 132(4):e139-e142. PubMed ID: 34384729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap After the Third Dose of BNT162b2 mRNA COVID-19 Vaccination and Literature Review.
    Jue MS; Joh HC; Kim SH; Ko JY
    Dermatitis; 2023; 34(2):158-159. PubMed ID: 36716204
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
    Petruzzi M; Galleggiante S; Messina S; Della Vella F
    BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stevens-Johnson syndrome precipitated by Moderna Inc. COVID-19 vaccine: a case-based review of literature comparing vaccine and drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Padniewski JJ; Jacobson-Dunlop E; Albadri S; Hylwa S
    Int J Dermatol; 2022 Aug; 61(8):923-929. PubMed ID: 35398905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
    Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
    BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An extremely rare mucocutaneous adverse reaction following COVID-19 vaccination: Toxic epidermal necrolysis.
    Mardani M; Mardani S; Asadi Kani Z; Hakamifard A
    Dermatol Ther; 2022 May; 35(5):e15416. PubMed ID: 35238119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
    Self WH; Tenforde MW; Rhoads JP; Gaglani M; Ginde AA; Douin DJ; Olson SM; Talbot HK; Casey JD; Mohr NM; Zepeski A; McNeal T; Ghamande S; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Erickson HL; Gong MN; Mohamed A; Henning DJ; Steingrub JS; Peltan ID; Brown SM; Martin ET; Monto AS; Khan A; Hough CL; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; Gordon AJ; Qadir N; Chang SY; Mallow C; Rivas C; Babcock HM; Kwon JH; Exline MC; Halasa N; Chappell JD; Lauring AS; Grijalva CG; Rice TW; Jones ID; Stubblefield WB; Baughman A; Womack KN; Lindsell CJ; Hart KW; Zhu Y; Mills L; Lester SN; Stumpf MM; Naioti EA; Kobayashi M; Verani JR; Thornburg NJ; Patel MM;
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(38):1337-1343. PubMed ID: 34555004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe cutaneous reaction to the messenger RNA (mRNA) BNT162b2 (Pfizer-BioNTech) vaccine.
    Sapsford S; Wood B
    N Z Med J; 2022 Oct; 135(1564):72-76. PubMed ID: 36302245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Steven-Johnson syndrome after COVID-19 vaccination.
    Mansouri P; Farshi S
    J Cosmet Dermatol; 2022 Apr; 21(4):1358-1360. PubMed ID: 35020263
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxic epidermal necrolysis and Stevens-Johnson syndrome after COVID-19 infection and vaccination.
    Zou H; Daveluy S
    Australas J Dermatol; 2023 Feb; 64(1):e1-e10. PubMed ID: 36484649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine.
    Luo A; Oakley A
    Australas J Dermatol; 2022 Aug; 63(3):e247-e250. PubMed ID: 35607272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TAFRO syndrome with a fatal clinical course following BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 vaccination: A case report.
    Yamada M; Sada RM; Kashihara E; Okubo G; Matsushita S; Manabe A; Tagawa S; Akebo H; Miyake H; Hatta K
    J Infect Chemother; 2022 Jul; 28(7):1008-1011. PubMed ID: 35428576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.
    Abraham N; Spruin S; Rossi T; Fireman B; Zafack J; Blaser C; Shaw A; Hutchings K; Ogunnaike-Cooke S
    Vaccine; 2022 Jul; 40(32):4663-4671. PubMed ID: 35750537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parsonage-Turner Syndrome After COVID-19 Vaccination in a Child.
    Cassart EM; Vilas DR; Abe R; Cavanilles-Walker JM
    J Am Acad Orthop Surg Glob Res Rev; 2023 Mar; 7(3):. PubMed ID: 36893168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [COVID-19 infections and effectiveness of the vaccination among healthcare workers].
    Rojkovich B; Németh D; Dinya E; Nagy E; Török E; Lázár I; Perduk A; Géher P; Nagy G
    Orv Hetil; 2023 Feb; 164(5):163-171. PubMed ID: 36739547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.